Relapsing Multiple Sclerosis
EMD SERONO--enrolling
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Aubagio, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Aubagio, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.
F. HOFFMANN-LA ROCHE LTD--enrolling
An observational study of ocrelizumab-treated patients with multiple sclerosis to determine the incidence and mortality rates of breast cancer and all malignancies (verismo study)
F. HOFFMANN-LA ROCHE LTD
A Phase 3 multicenter, randomized,double-blind, double-dummy,parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with teriflunomide in adult patients with relapsing multiple sclerosis
An observational study of ocrelizumab-treated patients with multiple sclerosis to determine the incidence and mortality rates of breast cancer and all malignancies (verismo study)
F. HOFFMANN-LA ROCHE LTD
A Phase 3 multicenter, randomized,double-blind, double-dummy,parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with teriflunomide in adult patients with relapsing multiple sclerosis
